0
     

Report Added
Report already added
Nucleic Vaccine Market in Brazil - Manufacturing and Consumption, Outlook and Forecast 2020-2026

Nucleic Vaccine Market in Brazil - Manufacturing and Consumption, Outlook and Forecast 2020-2026

A nucleic vaccine is to directly introduce an exogenous gene (DNA or RNA) encoding an antigen protein into an animal body cell, and synthesize the antigen protein through an expression system of a host cell to induce the host to produce an immune response to the antigen protein to achieve prevention And the purpose of treating the disease.

This report contains market size and forecasts of Nucleic Vaccine in Brazil, including the following market information:
Brazil Nucleic Vaccine Market Revenue, 2015-2020, 2021-2026, ($ millions)
Brazil Nucleic Vaccine Market Consumption, 2015-2020, 2021-2026, (K Units)
Brazil Nucleic Vaccine Production Capacity, 2015-2020, 2021-2026, (K Units)
Top Five Competitors in Brazil Nucleic Vaccine Market 2019 (%)
The global Nucleic Vaccine market was valued at xx million in 2019 and is projected to reach US$ xx million by 2026, at a CAGR of xx% during the forecast period. While the Nucleic Vaccine market size in Brazil was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nucleic Vaccine manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
This report also analyses and evaluates the COVID-19 impact on Nucleic Vaccine production and consumption in Brazil
Total Market by Segment:
Brazil Nucleic Vaccine Market, By Type, 2015-2020, 2021-2026 ($ millions) & (K Units)
Brazil Nucleic Vaccine Market Segment Percentages, By Type, 2019 (%)
Preventive Nucleic Vaccine
Therapeutic Nucleic Vaccine

Brazil Nucleic Vaccine Market, By Application, 2015-2020, 2021-2026 ($ millions) & (K Units)
Brazil Nucleic Vaccine Market Segment Percentages, By Application, 2019 (%)
Hospital
Clinic
Others

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Nucleic Vaccine Market Competitors Revenues in Brazil, by Players 2015-2020 (Estimated), ($ millions)
Total Nucleic Vaccine Market Competitors Revenues Share in Brazil, by Players 2019 (%)
Total Brazil Nucleic Vaccine Market Competitors Sales, by Players 2015-2020 (Estimated), (K Units)
Total Brazil Nucleic Vaccine Market Competitors Sales Market Share by Players 2019 ($ millions)
Further, the report presents profiles of competitors in the market, including the following:
Moderna
CureVac
Inovio
Sanofi
GSK
CNBG
Hualan Bio
Zhifei Shengwu
Liaoning Chengda
BioKangtai
CanSinoBIO
Walvax Biotechnology
Fosun Pharma
1 Introduction to Research & Analysis Reports
1.1 Nucleic Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Brazil Nucleic Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats

Brazil Nucleic Vaccine Overall Market Size
2.1 Brazil Nucleic Vaccine Market Size: 2020 VS 2026
2.2 Brazil Nucleic Vaccine Revenue, Prospects & Forecasts: 2015-2026
2.3 Brazil Nucleic Vaccine Sales (Consumption): 2015-2026

3 Company Landscape
3.1 Top Nucleic Vaccine Players in Brazil (including Foreign and Local Companies)
3.2 Top Brazil Nucleic Vaccine Companies Ranked by Revenue
3.3 Brazil Nucleic Vaccine Revenue by Companies (including Foreign and Local Companies)
3.4 Brazil Nucleic Vaccine Sales by Companies (including Foreign and Local Companies)
3.5 Brazil Nucleic Vaccine Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Nucleic Vaccine Companies in Brazil, by Revenue in 2019
3.7 Brazil Manufacturers Nucleic Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Nucleic Vaccine Players in Brazil
3.8.1 List of Brazil Tier 1 Nucleic Vaccine Companies
3.8.2 List of Brazil Tier 2 and Tier 3 Nucleic Vaccine Companies

4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Brazil Nucleic Vaccine Market Size Markets, 2020 & 2026
4.1.2 Preventive Nucleic Vaccine
4.1.3 Therapeutic Nucleic Vaccine
4.2 By Type - Brazil Nucleic Vaccine Revenue & Forecasts
4.2.1 By Type - Brazil Nucleic Vaccine Revenue, 2015-2020
4.2.2 By Type - Brazil Nucleic Vaccine Revenue, 2021-2026
4.2.3 By Type - Brazil Nucleic Vaccine Revenue Market Share, 2015-2026
4.3 By Type - Brazil Nucleic Vaccine Sales & Forecasts
4.3.1 By Type - Brazil Nucleic Vaccine Sales, 2015-2020
4.3.2 By Type - Brazil Nucleic Vaccine Sales, 2021-2026
4.3.3 By Type - Brazil Nucleic Vaccine Sales Market Share, 2015-2026
4.4 By Type - Brazil Nucleic Vaccine Price (Manufacturers Selling Prices), 2015-2026
5 Market Sights by Application
5.1 Overview
5.1.1 By Application - Brazil Nucleic Vaccine Market Size, 2020 & 2026
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Brazil Nucleic Vaccine Revenue & Forecasts
5.2.1 By Application - Brazil Nucleic Vaccine Revenue, 2015-2020
5.2.2 By Application - Brazil Nucleic Vaccine Revenue, 2021-2026
5.2.3 By Application - Brazil Nucleic Vaccine Revenue Market Share, 2015-2026
5.3 By Application - Brazil Nucleic Vaccine Sales & Forecasts
5.3.1 By Application - Brazil Nucleic Vaccine Sales, 2015-2020
5.3.2 By Application - Brazil Nucleic Vaccine Sales, 2021-2026
5.3.3 By Application - Brazil Nucleic Vaccine Sales Market Share, 2015-2026
5.4 By Application - Brazil Nucleic Vaccine Price (Manufacturers Selling Prices), 2015-2026
6 Manufacturers & Brands Profiles
6.1 Moderna
6.1.1 Moderna Corporate Summary
6.1.2 Moderna Business Overview
6.1.3 Moderna Nucleic Vaccine Major Product Offerings
6.1.4 Moderna Sales and Revenue in Brazil (2015-2020)
6.1.5 Moderna Key News
6.2 CureVac
6.2.1 CureVac Corporate Summary
6.2.2 CureVac Business Overview
6.2.3 CureVac Nucleic Vaccine Major Product Offerings
6.2.4 CureVac Sales and Revenue in Brazil (2015-2020)
6.2.5 CureVac Key News
6.3 Inovio
6.3.1 Inovio Corporate Summary
6.3.2 Inovio Business Overview
6.3.3 Inovio Nucleic Vaccine Major Product Offerings
6.3.4 Inovio Sales and Revenue in Brazil (2015-2020)
6.3.5 Inovio Key News
6.4 Sanofi
6.4.1 Sanofi Corporate Summary
6.4.2 Sanofi Business Overview
6.4.3 Sanofi Nucleic Vaccine Major Product Offerings
6.4.4 Sanofi Sales and Revenue in Brazil (2015-2020)
6.4.5 Sanofi Key News
6.5 GSK
6.5.1 GSK Corporate Summary
6.5.2 GSK Business Overview
6.5.3 GSK Nucleic Vaccine Major Product Offerings
6.5.4 GSK Sales and Revenue in Brazil (2015-2020)
6.5.5 GSK Key News
6.6 CNBG
6.6.1 CNBG Corporate Summary
6.6.2 CNBG Business Overview
6.6.3 CNBG Nucleic Vaccine Major Product Offerings
6.6.4 CNBG Sales and Revenue in Brazil (2015-2020)
6.6.5 CNBG Key News
6.7 Hualan Bio
6.6.1 Hualan Bio Corporate Summary
6.6.2 Hualan Bio Business Overview
6.6.3 Hualan Bio Nucleic Vaccine Major Product Offerings
6.4.4 Hualan Bio Sales and Revenue in Brazil (2015-2020)
6.7.5 Hualan Bio Key News
6.8 Zhifei Shengwu
6.8.1 Zhifei Shengwu Corporate Summary
6.8.2 Zhifei Shengwu Business Overview
6.8.3 Zhifei Shengwu Nucleic Vaccine Major Product Offerings
6.8.4 Zhifei Shengwu Sales and Revenue in Brazil (2015-2020)
6.8.5 Zhifei Shengwu Key News
6.9 Liaoning Chengda
6.9.1 Liaoning Chengda Corporate Summary
6.9.2 Liaoning Chengda Business Overview
6.9.3 Liaoning Chengda Nucleic Vaccine Major Product Offerings
6.9.4 Liaoning Chengda Sales and Revenue in Brazil (2015-2020)
6.9.5 Liaoning Chengda Key News
6.10 BioKangtai
6.10.1 BioKangtai Corporate Summary
6.10.2 BioKangtai Business Overview
6.10.3 BioKangtai Nucleic Vaccine Major Product Offerings
6.10.4 BioKangtai Sales and Revenue in Brazil (2015-2020)
6.10.5 BioKangtai Key News
6.11 CanSinoBIO
6.11.1 CanSinoBIO Corporate Summary
6.11.2 CanSinoBIO Nucleic Vaccine Business Overview
6.11.3 CanSinoBIO Nucleic Vaccine Major Product Offerings
6.11.4 CanSinoBIO Sales and Revenue in Brazil (2015-2020)
6.11.5 CanSinoBIO Key News
6.12 Walvax Biotechnology
6.12.1 Walvax Biotechnology Corporate Summary
6.12.2 Walvax Biotechnology Nucleic Vaccine Business Overview
6.12.3 Walvax Biotechnology Nucleic Vaccine Major Product Offerings
6.12.4 Walvax Biotechnology Sales and Revenue in Brazil (2015-2020)
6.12.5 Walvax Biotechnology Key News
6.13 Fosun Pharma
6.13.1 Fosun Pharma Corporate Summary
6.13.2 Fosun Pharma Nucleic Vaccine Business Overview
6.13.3 Fosun Pharma Nucleic Vaccine Major Product Offerings
6.13.4 Fosun Pharma Sales and Revenue in Brazil (2015-2020)
6.13.5 Fosun Pharma Key News

7 Nucleic Vaccine Production Capacity, Export and Import Analysis
7.1 Nucleic Vaccine Production Capacity and Value in Brazil, Situation Analysis and Prediction, 2015-2026
7.1.1 Brazil Nucleic Vaccine Production Capacity, 2015-2026
7.1.2 Brazil Nucleic Vaccine Production 2015-2026
7.1.3 Brazil Nucleic Vaccine Production Value 2015-2026
7.2 Key Local Nucleic Vaccine Manufacturers in Brazil
7.2.1 Brazil Key Local Nucleic Vaccine Manufacturers Production Capacity
7.2.2 Brazil Key Local Nucleic Vaccine Manufacturers Production
7.2.3 Brazil Key Local Nucleic Vaccine Manufacturers Production Value
7.2.4 The Proportion of Nucleic Vaccine Production Sold in Brazil and Sold Other Than Brazil by Manufacturers
7.3 Nucleic Vaccine Export and Import in Brazil
7.3.1 Brazil Nucleic Vaccine Export Market
7.3.2 Brazil Nucleic Vaccine Source of Imports

8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 PESTLE Analysis for Brazil Nucleic Vaccine Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints

9 Nucleic Vaccine Supply Chain Analysis
9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Nucleic Vaccine Distributors and Sales Agents in Brazil

10 Conclusion

11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 DisclaimerList of Tables
Table 1. Key Players of Nucleic Vaccine in Brazil
Table 2. Top Players in Brazil, Ranking by Revenue (2019)
Table 3. Brazil Nucleic Vaccine Revenue by Companies, (US$, Mn), 2015-2020
Table 4. Brazil Nucleic Vaccine Revenue Share by Companies, 2015-2020
Table 5. Brazil Nucleic Vaccine Sales by Companies, (K Units), 2015-2020
Table 6. Brazil Nucleic Vaccine Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Nucleic Vaccine Price (2015-2020) (US$/Unit)
Table 8. Brazil Manufacturers Nucleic Vaccine Product Type
Table 9. List of Brazil Tier 1 Nucleic Vaccine Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of Brazil Tier 2 and Tier 3 Nucleic Vaccine Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Nucleic Vaccine Revenue in Brazil (US$, Mn), 2015-2020
Table 12. By Type - Nucleic Vaccine Revenue in Brazil (US$, Mn), 2021-2026
Table 13. By Type - Nucleic Vaccine Sales in Brazil (K Units), 2015-2020
Table 14. By Type - Nucleic Vaccine Sales in Brazil (K Units), 2021-2026
Table 15. By Application - Nucleic Vaccine Revenue in Brazil, (US$, Mn), 2015-2020
Table 16. By Application - Nucleic Vaccine Revenue in Brazil, (US$, Mn), 2021-2026
Table 17. By Application - Nucleic Vaccine Sales in Brazil, (K Units), 2015-2020
Table 18. By Application - Nucleic Vaccine Sales in Brazil, (K Units), 2021-2026
Table 19. Moderna Corporate Summary
Table 20. Moderna Nucleic Vaccine Product Offerings
Table 21. Moderna Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2015-2020)
Table 22. CureVac Corporate Summary
Table 23. CureVac Nucleic Vaccine Product Offerings
Table 24. CureVac Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2015-2020)
Table 25. Inovio Corporate Summary
Table 26. Inovio Nucleic Vaccine Product Offerings
Table 27. Inovio Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2015-2020)
Table 28. Sanofi Corporate Summary
Table 29. Sanofi Nucleic Vaccine Product Offerings
Table 30. Sanofi Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2015-2020)
Table 31. GSK Corporate Summary
Table 32. GSK Nucleic Vaccine Product Offerings
Table 33. GSK Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2015-2020)
Table 34. CNBG Corporate Summary
Table 35. CNBG Nucleic Vaccine Product Offerings
Table 36. CNBG Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2015-2020)
Table 37. Hualan Bio Corporate Summary
Table 38. Hualan Bio Nucleic Vaccine Product Offerings
Table 39. Hualan Bio Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2015-2020)
Table 40. Zhifei Shengwu Corporate Summary
Table 41. Zhifei Shengwu Nucleic Vaccine Product Offerings
Table 42. Zhifei Shengwu Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2015-2020)
Table 43. Liaoning Chengda Corporate Summary
Table 44. Liaoning Chengda Nucleic Vaccine Product Offerings
Table 45. Liaoning Chengda Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2015-2020)
Table 46. BioKangtai Corporate Summary
Table 47. BioKangtai Nucleic Vaccine Product Offerings
Table 48. BioKangtai Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2015-2020)
Table 49. CanSinoBIO Corporate Summary
Table 50. CanSinoBIO Nucleic Vaccine Product Offerings
Table 51. CanSinoBIO Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2015-2020)
Table 52. Walvax Biotechnology Corporate Summary
Table 53. Walvax Biotechnology Nucleic Vaccine Product Offerings
Table 54. Walvax Biotechnology Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2015-2020)
Table 55. Fosun Pharma Corporate Summary
Table 56. Fosun Pharma Nucleic Vaccine Product Offerings
Table 57. Fosun Pharma Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2015-2020)
Table 58. Nucleic Vaccine Production Capacity (K Units) of Local Manufacturers in Brazil, 2015-2020
Table 59. Nucleic Vaccine Production (K Units) of Local Manufacturers in Brazil, 2015-2020
Table 60. Brazil Nucleic Vaccine Production Market Share of Local Manufacturers, 2015-2020
Table 61. Nucleic Vaccine Production Value (US$, Mn) of Local Manufacturers in Brazil, 2015-2020
Table 62. Brazil Nucleic Vaccine Production Value Market Share of Local Manufacturers, 2015-2020
Table 63. The Percentage of Nucleic Vaccine Production Sold in Brazil and Sold Other Than Brazil by Manufacturers
Table 64. The Percentage of Nucleic Vaccine Production Sold in Brazil and Sold Other Than Brazil by Manufacturers
Table 65. Brazil Nucleic Vaccine Sales (Consumption), Production, Export and Import, 2015-2020
Table 66. Raw Materials and Suppliers
Table 67. Nucleic Vaccine Downstream Clients in Brazil
Table 68. Nucleic Vaccine Distributors and Sales Agents in Brazil
List of Figures
Figure 1. Nucleic Vaccine Segment by Type
Figure 2. Nucleic Vaccine Segment by Application
Figure 3. Brazil Nucleic Vaccine Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Nucleic Vaccine Market Size in Brazil, (US$, Mn) & (K Units): 2020 VS 2026
Figure 6. Brazil Nucleic Vaccine Revenue, 2015-2026 (US$, Mn)
Figure 7. Nucleic Vaccine Sales in Brazil: 2015-2026 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Nucleic Vaccine Revenue in 2019
Figure 9. By Type - Brazil Nucleic Vaccine Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - Brazil Nucleic Vaccine Market Share, 2015-2020
Figure 11. By Type - Brazil Nucleic Vaccine Market Share, 2020-2026
Figure 12. By Type - Brazil Nucleic Vaccine Price (US$/Unit), 2015-2026
Figure 13. By Application - Nucleic Vaccine Revenue in Brazil (US$, Mn), 2020 & 2026
Figure 14. By Application - Brazil Nucleic Vaccine Market Share, 2015-2020
Figure 15. By Application - Brazil Nucleic Vaccine Market Share, 2020-2026
Figure 16. By Application -Brazil Nucleic Vaccine Price (US$/Unit), 2015-2026
Figure 17. Brazil Nucleic Vaccine Production Capacity (K Units), 2015-2026
Figure 18. Brazil Nucleic Vaccine Actual Output (K Units), 2015-2026
Figure 19. Brazil Nucleic Vaccine Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of Brazil Nucleic Vaccine Export Destination, 2019
Figure 21. The Source of Imports of Brazil Nucleic Vaccine, 2019
Figure 22. PEST Analysis for Brazil Nucleic Vaccine Market in 2020
Figure 23. Nucleic Vaccine Market Opportunities & Trends in Brazil
Figure 24. Nucleic Vaccine Market Drivers in Brazil
Figure 25. Nucleic Vaccine Market Restraints in Brazil
Figure 26. Nucleic Vaccine Industry Value Chain

Report Title: Nucleic Vaccine Market in Brazil - Manufacturing and Consumption, Outlook and Forecast 2020-2026


Your Details
Valid Invalid number

Related Report

SELECT A FORMAT

ADD TO CART BUY NOW